Dow Corning bankruptcy could expand global breast implant settlement fund.
This article was originally published in The Gray Sheet
Executive SummaryDOW CORNING CHAPTER 11 FILING COULD INCREASE GLOBAL SETTLEMENT FUNDS, according to plaintiff attorneys in the breast implant liability settlement. Dow Corning announced on May 15 that it filed for protection under Chapter 11 of the bankruptcy code with the U.S. Bankruptcy Court in Bay City, Michigan.
You may also be interested in...
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.
Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.